Back to today’s briefing

Story perspectives

Biomarker Testing Revolutionizes Colorectal Cancer Detection and Treatment

6/8/2025

26 2

Summary

Story summary

Dr. Smitha Krishnamurthi from the Cleveland Clinic emphasizes the vital role of biomarker testing in colorectal cancer. This essential testing not only facilitates early detection but also uncovers inherited risks and shapes treatment choices. Identifying key mutations such as PTEN, PIK3CA, and BRAF can significantly influence prognosis and therapy success, underscoring the need for timely testing to enhance patient outcomes.

1 of 1

Story summary

Dr. Smitha Krishnamurthi from the Cleveland Clinic emphasizes the vital role of biomarker testing in colorectal cancer. This essential testing not only facilitates early detection but also uncovers inherited risks and shapes treatment choices. Identifying key mutations such as PTEN, PIK3CA, and BRAF can significantly influence prognosis and therapy success, underscoring the need for timely testing to enhance patient outcomes.